The effect of coagulation factors polymorphisms on abortion

Narjes Feizollahi, Zeinab Deris Zayeri, Najme Moradi, Mahvash Zargar, Hadi Rezaeeyan

PDF(139 KB)
PDF(139 KB)
Front. Biol. ›› 2018, Vol. 13 ›› Issue (3) : 190-196. DOI: 10.1007/s11515-018-1500-8
REVIEW

The effect of coagulation factors polymorphisms on abortion

Author information +
History +

Abstract

OBJECTIVE: Recent studies showed coagulation factors play important role in controlling pregnancy duration in addition to controlling homeostasis. Recent studies showed several polymorphisms of coagulation factors genes increase the clot formation and lead to abortion. In this study, we evaluated the polymorphisms of coagulation factors and their effects on the development of the fetus.

MATERIAL and METHODS: Relevant literature was identified by a PubMed search (1988-2017) of English language papers using the terms Abortion, pregnancy woman, coagulation factor and polymorphism.

RESULT: Several polymorphisms of coagulation factors disturb the exchange of food and other materials between the fetus and the mother, and impairs the formation of the placenta during embryonic stages.

DISCUSSION: Evaluation of functional polymorphisms in coagulation factors gene during fetal development can be used as a prognostic factor in the prevention of the abortion.

Keywords

polymorphism / thrombosis / abortion / prognosis

Cite this article

Download citation ▾
Narjes Feizollahi, Zeinab Deris Zayeri, Najme Moradi, Mahvash Zargar, Hadi Rezaeeyan. The effect of coagulation factors polymorphisms on abortion. Front. Biol., 2018, 13(3): 190‒196 https://doi.org/10.1007/s11515-018-1500-8

References

[1]
Aarabi M, Memariani T, Arefi S, Aarabi M, Hantoosh Zadeh S, Akhondi M A, Modarressi M H (2011). Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion. J Matern Fetal Neonatal Med, 24(3): 545–548
CrossRef Pubmed Google scholar
[2]
Abbate R, Sofi F, Gensini F, Fatini C, Sticchi E, Fedi S (2002). Thrombophilias as risk factors for disorders of pregnancy and fetal damage. Pathophysiol Haemost Thromb, 32(5-6): 318–321
CrossRef Pubmed Google scholar
[3]
Al-Azzawie H F, Sabri S (2014). C677T and A1298C polymorphisms of Methylenetetrahydrofolate Reductase Gene in Iraqi Patients with Recurrent Abortion. Int J, 2(6): 227–234
[4]
Aleman M M, Byrnes J R, Wang J G, Tran R, Lam W A, Di Paola J, Mackman N, Degen J L, Flick M J, Wolberg A S (2014). Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest, 124(8): 3590–3600
CrossRef Pubmed Google scholar
[5]
Anokhin B A, Stribinskis V, Dean W L, Maurer M C (2017). Activation of factor XIII is accompanied by a change in oligomerization state. FEBS J, 284(22): 3849–3861
CrossRef Pubmed Google scholar
[6]
Antza C, Cifkova R, Kotsis V (2017). Hypertensive complications of pregnancy: A clinical overview. Metabolism: S0026-0495(17)30323-2
CrossRef Pubmed Google scholar
[7]
Avila-Vergara M, Felipe de Jesús Peraza-Garay, Noemí Meraz-Cruz, Cesar Hernandez-Guerrero, Berenice Palacios-Gonzalez, Felipe Vadillo-Ortega (2018). Association of Intron-2 Variable Numbers of an 86-bp Tandem Repeat-Polymorphisms of Interleukin-1 Receptor Antagonist Gene and Idiopathic Recurrent Spontaneous Abortion. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 70(2): 96–102
[8]
Badenhop R F, Wang X L, Wilcken D E (1995). Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation, 91(6): 1655–1658
CrossRef Pubmed Google scholar
[9]
Bailey L B, Gregory J F 3rd (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr, 129(5): 919–922
CrossRef Pubmed Google scholar
[10]
Barlik M, Seremak-Mrozikiewicz A, Drews K, Klejewski A, Kurzawińska G, Łowicki Z, Wolski H (2016). Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage. Ginekol Pol, 87(7): 504–509
CrossRef Pubmed Google scholar
[11]
Ben-Ami I, Fuchs N, Schneider D, Pansky M, Halperin R, the BEN‐AMI (2012). Coagulopathy associated with dilation and evacuation for second-trimester abortion. Acta Obstet Gynecol Scand, 91(1): 10–15
CrossRef Pubmed Google scholar
[12]
Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler C J (2003). Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod, 18(11): 2473–2477
CrossRef Pubmed Google scholar
[13]
Cardenas J C, Matijevic N, Baer L A, Holcomb J B, Cotton B A, Wade C E (2014). Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock, 41(6): 514–521
CrossRef Pubmed Google scholar
[14]
Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, Girolami A, Bernardi F (2000). Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood, 96(4): 1443–1448
Pubmed
[15]
Chen Z, Xu F, Wei Y, Liu F, Qi H (2012). Angiotensin converting enzyme insertion/deletion polymorphism and risk of pregnancy hypertensive disorders: a meta-analysis. J Renin Angiotensin Aldosterone Syst, 13(1): 184–195
CrossRef Pubmed Google scholar
[16]
Chodirker B N, Dawson A J (2011). Recurrent miscarriage. N Engl J Med, 364(8): 783–784
CrossRef Pubmed Google scholar
[17]
Coolman M, de Groot C J M, Steegers E A P, Geurts-Moespot A, Thomas C M G, Steegers-Theunissen R P M, Sweep F C G J (2006). Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol, 128(1-2): 22–28
CrossRef Pubmed Google scholar
[18]
D’Elia P Q, dos Santos A A, Bianco B, Barbosa C P, Christofolini D M, Aoki T (2014). MTHFR polymorphisms C677T and A1298C and associations with IVF outcomes in Brazilian women. Reprod Biomed Online, 28(6): 733–738
CrossRef Pubmed Google scholar
[19]
Djurovic J, Stojkovic O, Todorovic J, Brajic A, Stankovic S, Obradovic S, Stamenkovic G (2017). Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations. Hum Fertil (Camb), 20(2): 132–139
CrossRef Pubmed Google scholar
[20]
Dorgalaleh A, Rashidpanah J (2016). Blood coagulation factor XIII and factor XIII deficiency. Blood Rev, 30(6): 461–475
CrossRef Pubmed Google scholar
[21]
Egerup P, Kolte A M, Larsen E C, Krog M, Nielsen H S, Christiansen O B (2016). Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod, 31(11): 2428–2434
CrossRef Pubmed Google scholar
[22]
ElDanasori N, Abulata N, Shaheen I A, ElGendy A M, El-Khayat W (2017). Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion. Clin Appl Thromb Hemost, 24 (3): 532-535
Pubmed
[23]
Elkin A C, Higham J (2000). Folic acid supplements are more effective than increased dietary folate intake in elevating serum folate levels. BJOG, 107(2): 285–289
CrossRef Pubmed Google scholar
[24]
Festa A, D’Agostino R Jr, Rich S S, Jenny N S, Tracy R P, Haffner S M (2003). Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation, 107(19): 2422–2427
CrossRef Pubmed Google scholar
[25]
Ford J G, Li Y, O’Sullivan M M, Demopoulos R, Garte S, Taioli E, Brandt-Rauf P W (2000). Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis, 21(11): 1971–1975
CrossRef Pubmed Google scholar
[26]
Franssen M T, Nico J Leschot, Patrick M M Bossuyt, Alida C Knegt, Klasien B J Gerssen-Schoorl, Cokkie H Wouters, Kerstin B M Hansson, Ron Hochstenbach, Kamlesh Madan, Fulco van der Veen, Mariette Goddijn (2005). Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ, 331(7509): 137–141
[27]
Garlantézec R, Chevrier C, Coiffec I, Celebi C, Cordier S (2012). Combined effect of prenatal solvent exposure and GSTT1 or GSTM1 polymorphisms in the risk of birth defects. Birth Defects Res A Clin Mol Teratol, 94(6): 481–485
CrossRef Pubmed Google scholar
[28]
Glueck C J, Wang P, Goldenberg N, Sieve L (2004). Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin. Clin Appl Thromb Hemost, 10(4): 323–334
CrossRef Pubmed Google scholar
[29]
Guerra-Shinohara E M, Bertinato J F, Tosin Bueno C, Cordeiro da Silva K, Burlacchini de Carvalho M H, Pulcineli Vieira Francisco R, Zugaib M, Cerda A, Morelli V M (2012). Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss. Thromb Haemost, 108(4): 693–700
Pubmed
[30]
Hayashi Y, Sasaki H, Suzuki S, Nishiyama T, Kitaori T, Mizutani E, Suzumori N, Sugiura-Ogasawara M (2013). Genotyping analyses for polymorphisms of ANXA5 gene in patients with recurrent pregnancy loss. Fertil Steril, 100(4): 1018–1024
CrossRef Pubmed Google scholar
[31]
James A H (2009). Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol, 29(3): 326–331
CrossRef Pubmed Google scholar
[32]
Jeddi-Tehrani M, Torabi R, Mohammadzadeh A, Arefi S, Keramatipour M, Zeraati H, Zarnani A H, Akhondi M M, Mahmoudian J, Mahmoudi A R, Zarei S (2010). Investigating association of three polymorphisms of coagulation factor XIII and recurrent pregnancy loss. Am J Reprod Immunol, 64(3): 212–217
CrossRef Pubmed Google scholar
[33]
Kamimoto Y, Wada H, Ikejiri M, Nakatani K, Sugiyama T, Osato K, Murabayashi N, Habe K, Mizutani H, Matsumoto T, Ohishi K, Ikeda T (2017). Hypofibrinogenemia and the a-Fibrinogen Thr312Ala polymorphism may be risk factors for early pregnancy loss. Clin Appl Thromb Hemost, 23(1): 52–57
CrossRef Pubmed Google scholar
[34]
Karatas A, Eroz R, Albayrak M, Ozlu T, Cakmak B, Keskin F (2014). Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage. Afr Health Sci, 14(1): 216–222
CrossRef Pubmed Google scholar
[35]
Karimlo F K, Mashayekhi F, Sorouri Z Z, Bahador M H, Salehi Z (2015). Association of GSTM1 and GSTT1 gene polymorphisms and in-vitro fertilisation outcome in a population in northern Iran. J Obstet Gynaecol, 35(1): 46–48
CrossRef Pubmed Google scholar
[36]
Kim S Y, Park S Y, Choi J W, Kim D J, Lee S Y, Lim J H, Han J Y, Ryu H M, Kim M H (2011). Association between MTHFR 1298A>C polymorphism and spontaneous abortion with fetal chromosomal aneuploidy. Am J Reprod Immunol, 66(4): 252–258
CrossRef Pubmed Google scholar
[37]
Kohler H P (2001). Role of blood coagulation factor XIII in vascular diseases. Swiss Med Wkly, 131(3-4): 31–34
Pubmed
[38]
Kotze M J, La Grange C, Mansvelt E (2005). Genetics in family practice: rapid thrombophilia genetic test facilitates improved prenatal care for mother and child. S Afr Fam Pract, 47(7): 50–51
CrossRef Google scholar
[39]
Kuhli C, Lüchtenberg M, Scharrer I, Hattenbach L O (2005). Massive subhyaloidal hemorrhage associated with severe PAI-1 deficiency. Graefes Arch Clin Exp Ophthalmol, 243(10): 963–966
CrossRef Pubmed Google scholar
[40]
Kupferminc M J (2003). Thrombophilia and pregnancy. Reprod Biol Endocrinol, 1(1): 111
CrossRef Pubmed Google scholar
[41]
Kurzawińska G, Seremak-Mrozikiewicz A, Drews K, Barlik M, Mrozikiewicz P M (2009). (Genetic conditioned changes in activity of 5,10-methylenetetrahydrofolate reductase (MTHFR) and recurrent miscarriages). Ginekol Pol, 80(10): 762–767
Pubmed
[42]
López-Jiménez J, Porras-Dorantes Á, Juárez-Vázquez C I, García-Ortiz J E, Fuentes-Chávez C A, Lara-Navarro I J, Jaloma-Cruz A R (2016). Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss. Genet Mol Res, 15(4)
CrossRef Google scholar
[43]
Luo Y, Wang C, Tu H (2014). Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome. Mol Med Rep, 9(3): 894–898
CrossRef Pubmed Google scholar
[44]
Lyall F, Bulmer J N, Duffie E, Cousins F, Theriault A, Robson S C (2001). Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol, 158(5): 1713–1721
CrossRef Pubmed Google scholar
[45]
MacCallum P, Bowles L, Keeling D (2014). Diagnosis and management of heritable thrombophilias. BMJ, 349(7967): g4387
[46]
Masini S, Ticconi C, Gravina P, Tomassini M, Pietropolli A, Forte V, Federici G, Piccione E, Bernardini S (2009). Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss. Fertil Steril, 92(2): 694–702
CrossRef Pubmed Google scholar
[47]
Matsumoto T, Nogami K, Shima M (2013). Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost, 110(4): 761–768
CrossRef Pubmed Google scholar
[48]
Medicine P C A S R, and the Practice Committee of American Society for Reproductive Medicine (2013). Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril, 99(1): 63
CrossRef Pubmed Google scholar
[49]
Middeldorp S (2007). Pregnancy failure and heritable thrombophilia. in Seminars in hematology. Elsevier
[50]
Mowla K, Rajaei E, Jalali M T, Zayeri Z D (2018). Threatening biomarkers in lupus pregnancy: Biochemistry and genetic challenges. Front Biol: 13 (1) : 1–8
[51]
Mtiraoui N, Borgi L, Gris J C, Almawi W Y, Mahjoub T (2004). Factor V Leiden, prothrombin G20210A and antibodies against phospholipids in recurrent spontaneous abortion. J Thromb Haemost, 2(8): 1482–1484
CrossRef Pubmed Google scholar
[52]
Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan R R, Gris J C, Almawi W Y, Mahjoub T (2005). Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol, 119(2): 164–170
CrossRef Pubmed Google scholar
[53]
Muszbek L, Katona É ( 2016). Diagnosis and management of congenital and acquired FXIII deficiencies. in Seminars in thrombosis and hemostasis. Thieme Medical Publishers
[54]
Naderi M, Dorgalaleh A, Tabibian Sh, Alizadeh Sh, Eshghi P, Solaimani G (2013). Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol, 3(4): 164–172
Pubmed
[55]
Pereza N, Ostojić S, Kapović M, Peterlin B (2017). Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. Fertil Steril, 107(1): 150–159
[56]
Pickering W, Marriott K, Regan L (2001). G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost, 7(1): 25–28
CrossRef Pubmed Google scholar
[57]
Prat M, Morales-Indiano C, Jimenez C, Mas V, Besses C, Checa M A, Carreras R (2014). “20209C-T” a variant mutation of prothrombin gene mutation in a patient with recurrent pregnancy loss. Ann Clin Lab Sci, 44(3): 334–336
Pubmed
[58]
Qublan H S, Eid S S, Ababneh H A, Amarin Z O, Smadi A Z, Al-Khafaji F F, Khader Y S (2006). Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod, 21(10): 2694–2698
CrossRef Pubmed Google scholar
[59]
Rezaeeyan H, Jaseb K, Alghasi A, Asnafi A A, Saki N (2017). Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. Blood Coagul Fibrinolysis, 28(8): 617–622
CrossRef Pubmed Google scholar
[60]
Rijken D C, Lijnen H R (2009). New insights into the molecular mechanisms of the fibrinolytic system. J Thromb Haemost, 7(1): 4–13
CrossRef Pubmed Google scholar
[61]
Sata F, Yamada H, Kondo T, Gong Y, Tozaki S, Kobashi G, Kato EH, Fujimoto S, Kishi R (2003). Glutathione S‐transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. MHR: Basic science of reproductive medicine, 9(3): 165–169
[62]
Shi Q, Hu M, Luo M, Liu Q, Jiang F, Zhang Y, Wang S, Yan C, Weng Y (2011). Reduced expression of Mad2 and Bub1 proteins is associated with spontaneous miscarriages. Mol Hum Reprod, 17(1): 14–21
CrossRef Pubmed Google scholar
[63]
Simcox L E, Ormesher L, Tower C, Greer I A (2015). Thrombophilia and pregnancy complications. Int J Mol Sci, 16(12): 28418–28428
CrossRef Pubmed Google scholar
[64]
Su M T, Lin S H, Chen Y C, Kuo P L (2013). Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost, 109(1): 8–15
Pubmed
[65]
Tulandi, T. and Al-FozanH., Definition and etiology of recurrent pregnancy loss. Up To Date Last updated, 2011. 16.
[66]
Tusskorn O, Khunluck T, Prawan A, Senggunprai L, Kukongviriyapan U, Kukongviriyapan V (2018). Suppression of glutathione S-transferases potentiates the cytotoxic effect of phenethyl isothiocyanate in cholangiocarcinoma cells. Naunyn Schmiedebergs Arch Pharmacol, 391(6): 657–667
Pubmed
[67]
Van der Put, N., van der Molen E F, Kluijtmans L A, Heil S G, Trijbels J M, Eskes T K, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom H J (1997). Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM, 90(8): 511–517
[68]
Vívenes-de Lugo M, Alvaro R L, Belsy G, Dinorah C D G (2008). Ethnic/geographic variation of the val34leu polymorphism of coagulation factor XIII and its distribution in American admixed populations. Internet J Biol Anthropol, 2: 1
[69]
Vora S, Shetty S, Khare M, Ghosh K (2009). Placental histomorphology in unexplained foetal loss with thrombophilia. Indian J Med Res, 129(2): 144–149
Pubmed
[70]
Walton B L, Byrnes J R, Wolberg A S (2015). Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost, 13(Suppl 1): S208–S215
CrossRef Pubmed Google scholar
[71]
Wang H Y, Qiao J, Sun X X, Wang S Y, Liang X Y, Sun Y, Liu F H (2017). Epidemiological Survey and Risk Factor Analysis of Recurrent Spontaneous Miscarriages in Infertile Women at Large Infertility Centers. Chin Med J (Engl), 130(17): 2056–2062
CrossRef Pubmed Google scholar
[72]
Wolski H, Barlik M, Drews K, Klejewski A, Kurzawińska G, Ożarowski M, Łowicki Z, Seremak-Mrozikiewicz A (2017). Contribution of inherited thrombophilia to recurrent miscarriage in the Polish population. Ginekol Pol, 88(7): 385–392
CrossRef Pubmed Google scholar

Authors’ contributions

H.R. conceived the manuscript and revised it; N.F., Z.D., N.M. and M.Z. wrote the manuscript.

Acknowledgments

We wish to thank all our colleagues in Golestan Hospital clinical research development unit, Ahvaz Jundishapur University of Medical Sciences.

Conflict of interest

Authors declare that they have no conflict of interest.

RIGHTS & PERMISSIONS

2018 Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature
PDF(139 KB)

Accesses

Citations

Detail

Sections
Recommended

/